Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
1986 1
1988 2
1989 3
1990 5
1991 4
1992 4
1993 2
1994 4
1996 4
1997 1
1998 3
1999 1
2000 1
2001 1
2002 6
2004 1
2005 2
2006 3
2007 3
2008 2
2009 1
2010 2
2011 1
2012 2
2013 2
2015 1
2016 4
2017 2
2018 8
2019 2
2020 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Pujade-Lauraine E, Ledermann JA, Selle F, Gebski V, Penson RT, Oza AM, Korach J, Huzarski T, Poveda A, Pignata S, Friedlander M, Colombo N, Harter P, Fujiwara K, Ray-Coquard I, Banerjee S, Liu J, Lowe ES, Bloomfield R, Pautier P; SOLO2/ENGOT-Ov21 investigators. Pujade-Lauraine E, et al. Lancet Oncol. 2017 Sep;18(9):1274-1284. doi: 10.1016/S1470-2045(17)30469-2. Epub 2017 Jul 25. Lancet Oncol. 2017. PMID: 28754483 Free article. Clinical Trial.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Poveda A, Floquet A, Ledermann JA, Asher R, Penson RT, Oza AM, Korach J, Huzarski T, Pignata S, Friedlander M, Baldoni A, Park-Simon TW, Tamura K, Sonke GS, Lisyanskaya A, Kim JH, Filho EA, Milenkova T, Lowe ES, Rowe P, Vergote I, Pujade-Lauraine E; SOLO2/ENGOT-Ov21 investigators. Poveda A, et al. Lancet Oncol. 2021 May;22(5):620-631. doi: 10.1016/S1470-2045(21)00073-5. Epub 2021 Mar 18. Lancet Oncol. 2021. PMID: 33743851 Clinical Trial.
New membership model.
Burke T, Chalas E. Burke T, et al. Among authors: chalas e. Gynecol Oncol. 2009 Jan;112(1):4-5. doi: 10.1016/j.ygyno.2008.11.036. Gynecol Oncol. 2009. PMID: 19100915 No abstract available.
Morcellation in gynecologic oncology.
Chalas E. Chalas E. Curr Opin Obstet Gynecol. 2018 Feb;30(1):96-98. doi: 10.1097/GCO.0000000000000429. Curr Opin Obstet Gynecol. 2018. PMID: 29251679 Review.
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: JACC: CardioOncology State-of-the-Art Review.
Parashar S, Akhter N, Paplomata E, Elgendy IY, Upadhyaya D, Scherrer-Crosbie M, Okwuosa TM, Sanghani RM, Chalas E, Lindley KJ, Dent S. Parashar S, et al. Among authors: chalas e. JACC CardioOncol. 2023 Apr 18;5(2):159-173. doi: 10.1016/j.jaccao.2023.02.002. eCollection 2023 Apr. JACC CardioOncol. 2023. PMID: 37144116 Free PMC article. Review.
In Reply.
Parker WH, Kaunitz AM, Pritts EA, Olive DL, Chalas E, Clarke-Pearson DL, Berek JS; Leiomyoma Morcellation Review Group. Parker WH, et al. Among authors: chalas e. Obstet Gynecol. 2016 May;127(5):966-967. doi: 10.1097/AOG.0000000000001416. Obstet Gynecol. 2016. PMID: 27101114 No abstract available.
NSQIP--the new frontier?
Chalas E, Brown JV, Cliby W. Chalas E, et al. Gynecol Oncol. 2008 Nov;111(2):163-5. doi: 10.1016/j.ygyno.2008.07.046. Gynecol Oncol. 2008. PMID: 19086267 No abstract available.
Ovaries, estrogen, and longevity.
Chalas E. Chalas E. Obstet Gynecol. 2013 Apr;121(4):701-702. doi: 10.1097/AOG.0b013e31828af732. Obstet Gynecol. 2013. PMID: 23635666 No abstract available.
81 results